{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:26:34Z","timestamp":1792736794248,"version":"4.5.0"},"reference-count":50,"publisher":"American Society of Hematology","issue":"2","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,7,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The functional analysis of the common prothrombin 20210 G&amp;gt;A(F2 20210*A) mutation has recently revealed gain of function of 3\u2032end processing as a novel genetic mechanism predisposing to human disease. We now show that the physiologic G at the cleavage site at position 20210 is the functionally least efficient nucleotide to support 3\u2032end processing but has evolved to be physiologically optimal. Furthermore, the F2 3\u2032end processing signal is characterized by a weak downstream cleavage stimulating factor (CstF) binding site with a low uridine density, and the functional efficiency of F2 3\u2032end processing can be enhanced by the introduction of additional uridine residues. The recently identified thrombosis-related mutation (F2 20221*T) within the CstF binding site up-regulates F2 3\u2032end processing and prothrombin biosynthesis in vivo. F2 20221*T thus represents the first example of a likely pathologically relevant mutation of the putative CstF binding site in the 3\u2032flanking sequence of a human gene. Finally, we show that the low-efficiency F2 cleavage and CstF binding sites are balanced by a stimulatory upstream uridine-rich element in the 3\u2032UTR. The architecture of the F2 3\u2032end processing signal is thus characterized by a delicate balance of positive and negative signals. This balance appears to be highly susceptible to being disturbed by clinically relevant gain-of-function mutations. (Blood. 2004;104:428-435)<\/jats:p>","DOI":"10.1182\/blood-2003-08-2894","type":"journal-article","created":{"date-parts":[[2004,4,6]],"date-time":"2004-04-06T00:13:07Z","timestamp":1081210387000},"page":"428-435","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":64,"title":["The prothrombin 3\u2032end formation signal reveals a unique architecture that is sensitive to thrombophilic gain-of-function mutations"],"prefix":"10.1182","volume":"104","author":[{"given":"Sven","family":"Danckwardt","sequence":"first","affiliation":[{"name":"From the Department of Pediatric Oncology, Hematology and Immunology, University of Heidelberg, Germany; EMBL\u2014University of Heidelberg Molecular Medicine Partnership Unit, Germany; and European Molecular Biology Laboratory (EMBL), Heidelberg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels H.","family":"Gehring","sequence":"additional","affiliation":[{"name":"From the Department of Pediatric Oncology, Hematology and Immunology, University of Heidelberg, Germany; EMBL\u2014University of Heidelberg Molecular Medicine Partnership Unit, Germany; and European Molecular Biology Laboratory (EMBL), Heidelberg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Neu-Yilik","sequence":"additional","affiliation":[{"name":"From the Department of Pediatric Oncology, Hematology and Immunology, University of Heidelberg, Germany; EMBL\u2014University of Heidelberg Molecular Medicine Partnership Unit, Germany; and European Molecular Biology Laboratory (EMBL), Heidelberg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Hundsdoerfer","sequence":"additional","affiliation":[{"name":"From the Department of Pediatric Oncology, Hematology and Immunology, University of Heidelberg, Germany; EMBL\u2014University of Heidelberg Molecular Medicine Partnership Unit, Germany; and European Molecular Biology Laboratory (EMBL), Heidelberg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margit","family":"Pforsich","sequence":"additional","affiliation":[{"name":"From the Department of Pediatric Oncology, Hematology and Immunology, University of Heidelberg, Germany; EMBL\u2014University of Heidelberg Molecular Medicine Partnership Unit, Germany; and European Molecular Biology Laboratory (EMBL), Heidelberg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ute","family":"Frede","sequence":"additional","affiliation":[{"name":"From the Department of Pediatric Oncology, Hematology and Immunology, University of Heidelberg, Germany; EMBL\u2014University of Heidelberg Molecular Medicine Partnership Unit, Germany; and European Molecular Biology Laboratory (EMBL), Heidelberg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias W.","family":"Hentze","sequence":"additional","affiliation":[{"name":"From the Department of Pediatric Oncology, Hematology and Immunology, University of Heidelberg, Germany; EMBL\u2014University of Heidelberg Molecular Medicine Partnership Unit, Germany; and European Molecular Biology Laboratory (EMBL), Heidelberg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas E.","family":"Kulozik","sequence":"additional","affiliation":[{"name":"From the Department of Pediatric Oncology, Hematology and Immunology, University of Heidelberg, Germany; EMBL\u2014University of Heidelberg Molecular Medicine Partnership Unit, Germany; and European Molecular Biology Laboratory (EMBL), Heidelberg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021223275779100_REF1","doi-asserted-by":"crossref","unstructured":"Dahlback B. Blood coagulation. Lancet.2000; 355: 1627-1632.","DOI":"10.1016\/S0140-6736(00)02225-X"},{"key":"2020021223275779100_REF2","doi-asserted-by":"crossref","unstructured":"Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3\u2032-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood.1996;88: 3698-3703.","DOI":"10.1182\/blood.V88.10.3698.bloodjournal88103698"},{"key":"2020021223275779100_REF3","doi-asserted-by":"crossref","unstructured":"Cattaneo M, Chantarangkul V, Taioli E, Santos JH, Tagliabue L. The G20210A mutation of the prothrombin gene in patients with previous first episodes of deep-vein thrombosis: prevalence and association with factor V G1691A, methylenetetrahydrofolate reductase C677T and plasma prothrombin levels. Thromb Res.1999; 93: 1-8.","DOI":"10.1016\/S0049-3848(98)00136-4"},{"key":"2020021223275779100_REF4","doi-asserted-by":"crossref","unstructured":"Makris M, Preston FE, Beauchamp NJ, et al. Coinheritance of the 20210A allele of the prothrombin gene increases the risk of thrombosis in subjects with familial thrombophilia. Thromb Haemost.1997;78: 1426-1429.","DOI":"10.1055\/s-0038-1665427"},{"key":"2020021223275779100_REF5","doi-asserted-by":"crossref","unstructured":"Soria JM, Almasy L, Souto JC, et al. Linkage analysis demonstrates that the prothrombin G20210A mutation jointly influences plasma prothrombin levels and risk of thrombosis. Blood.2000;95: 2780-2785.","DOI":"10.1182\/blood.V95.9.2780.009k36_2780_2785"},{"key":"2020021223275779100_REF6","doi-asserted-by":"crossref","unstructured":"Gehring NH, Frede U, Neu-Yilik G, et al. Increased efficiency of mRNA 3\u2032 end formation: a new genetic mechanism contributing to hereditary thrombophilia. Nat Genet.2001;28: 389-392.","DOI":"10.1038\/ng578"},{"key":"2020021223275779100_REF7","doi-asserted-by":"crossref","unstructured":"Ceelie H, Spaargaren-van Riel CC, Bertina RM, Vos HL. G20210A is a functional mutation in the prothrombin gene; effect on protein levels and 3\u2032-end formation. J Thromb Haemost.2004;2: 119-127.","DOI":"10.1111\/j.1538-7836.2003.00493.x"},{"key":"2020021223275779100_REF8","doi-asserted-by":"crossref","unstructured":"Pollak ES, Lam HS, Russell JE. The G20210A mutation does not affect the stability of prothrombin mRNA in vivo. Blood.2002;100: 359-362.","DOI":"10.1182\/blood-2002-02-0412"},{"key":"2020021223275779100_REF9","doi-asserted-by":"crossref","unstructured":"Colgan DF, Manley JL. Mechanism and regulation of mRNA polyadenylation. Genes Dev.1997; 11: 2755-2766.","DOI":"10.1101\/gad.11.21.2755"},{"key":"2020021223275779100_REF10","doi-asserted-by":"crossref","unstructured":"Keller W, Minvielle-Sebastia L. A comparison of mammalian and yeast pre-mRNA 3\u2032-end processing. Curr Opin Cell Biol.1997;9: 329-336.","DOI":"10.1016\/S0955-0674(97)80004-X"},{"key":"2020021223275779100_REF11","doi-asserted-by":"crossref","unstructured":"Beyer K, Dandekar T, Keller W. RNA ligands selected by cleavage stimulation factor contain distinct sequence motifs that function as downstream elements in 3\u2032-end processing of premRNA. J Biol Chem.1997;272: 26769-26779.","DOI":"10.1074\/jbc.272.42.26769"},{"key":"2020021223275779100_REF12","doi-asserted-by":"crossref","unstructured":"Chen F, MacDonald CC, Wilusz J. Cleavage site determinants in the mammalian polyadenylation signal. Nucleic Acids Res.1995;23: 2614-2620.","DOI":"10.1093\/nar\/23.14.2614"},{"key":"2020021223275779100_REF13","doi-asserted-by":"crossref","unstructured":"Higgs DR, Goodbourn SE, Lamb J, Clegg JB, Weatherall DJ, Proudfoot NJ. Alpha-thalassaemia caused by a polyadenylation signal mutation. Nature.1983;306: 398-400.","DOI":"10.1038\/306398a0"},{"key":"2020021223275779100_REF14","doi-asserted-by":"crossref","unstructured":"Orkin SH, Cheng TC, Antonarakis SE, Kazazian HH Jr. Thalassemia due to a mutation in the cleavage-polyadenylation signal of the human beta-globin gene. EMBO J.1985;4: 453-456.","DOI":"10.1002\/j.1460-2075.1985.tb03650.x"},{"key":"2020021223275779100_REF15","doi-asserted-by":"crossref","unstructured":"Jankovic L, Efremov GD, Petkov G, et al. Two novel polyadenylation mutations leading to beta(+)-thalassemia. Br J Haematol.1990;75: 122-126.","DOI":"10.1111\/j.1365-2141.1990.tb02627.x"},{"key":"2020021223275779100_REF16","doi-asserted-by":"crossref","unstructured":"Rund D, Dowling C, Najjar K, Rachmilewitz E, Kazazian H Jr, Oppenheim A. Two mutations in the beta-globin polyadenylylation signal reveal extended transcripts and new RNA polyadenylylation sites. Proc Natl Acad Sci U S A.1992;89: 4324-4328.","DOI":"10.1073\/pnas.89.10.4324"},{"key":"2020021223275779100_REF17","doi-asserted-by":"crossref","unstructured":"Harteveld CL, Losekoot M, Haak H, Heister GA, Giordano PC, Bernini LF. A novel polyadenylation signal mutation in the alpha 2-globin gene causing alpha thalassaemia. Br J Haematol.1994;87: 139-143.","DOI":"10.1111\/j.1365-2141.1994.tb04883.x"},{"key":"2020021223275779100_REF18","unstructured":"van Solinge WW, Lind B, van Wijk R, Hart HC, Kraaijenhagen RJ. Clinical expression of a rare beta-globin gene mutation co-inherited with haemoglobin E-disease. Eur J Clin Chem Clin Biochem.1996;34: 949-954."},{"key":"2020021223275779100_REF19","doi-asserted-by":"crossref","unstructured":"Barth ML, Fensom A, Harris A. Prevalence of common mutations in the arylsulphatase A gene in metachromatic leukodystrophy patients diagnosed in Britain. Hum Genet.1993;91: 73-77.","DOI":"10.1007\/BF00230227"},{"key":"2020021223275779100_REF20","unstructured":"Bell DA, Stephens EA, Castranio T, et al. Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer. Cancer Res.1995;55: 3537-3542."},{"key":"2020021223275779100_REF21","doi-asserted-by":"crossref","unstructured":"Kleiman FE, Manley JL. Functional interaction of BRCA1-associated BARD1 with polyadenylation factor CstF-50. Science.1999;285: 1576-1579.","DOI":"10.1126\/science.285.5433.1576"},{"key":"2020021223275779100_REF22","doi-asserted-by":"crossref","unstructured":"Wylenzek M, Geisen C, Stapenhorst L, Wielckens K, Klingler KR. A novel point mutation in the 3\u2032 region of the prothrombin gene at position 20221 in a Lebanese\/Syrian family. Thromb Haemost.2001;85: 943-944.","DOI":"10.1055\/s-0037-1615777"},{"key":"2020021223275779100_REF23","doi-asserted-by":"crossref","unstructured":"Balim Z, Kosova B, Falzon K, Bezzina Wettinger S, Colak Y. Budd-Chiari syndrome in a patient heterozygous for the point mutation C20221T of the prothrombin gene. J Thromb Haemost.2003; 1: 852-853.","DOI":"10.1046\/j.1538-7836.2003.t01-2-00115.x"},{"key":"2020021223275779100_REF24","doi-asserted-by":"crossref","unstructured":"Gehring NH, Neu-Yilik G, Schell T, Hentze MW, Kulozik AE. Y14 and hUpf3b form an NMD-activating complex. Mol Cell.2003;11: 939-949.","DOI":"10.1016\/S1097-2765(03)00142-4"},{"key":"2020021223275779100_REF25","doi-asserted-by":"crossref","unstructured":"Thermann R, Neu-Yilik G, Deters A, et al. Binary specification of nonsense codons by splicing and cytoplasmic translation. EMBO J.1998;17: 3484-3494.","DOI":"10.1093\/emboj\/17.12.3484"},{"key":"2020021223275779100_REF26","doi-asserted-by":"crossref","unstructured":"Salle\u0301s FJ, Richards WG, Strickland S. Assaying the polyadenylation state of mRNAs. Methods.1999;17: 38-45.","DOI":"10.1006\/meth.1998.0705"},{"key":"2020021223275779100_REF27","doi-asserted-by":"crossref","unstructured":"Danckwardt S, Neu-Yilik G, Thermann R, Frede U, Hentze MW, Kulozik AE. Abnormally spliced beta-globin mRNAs: a single point mutation generates transcripts sensitive and insensitive to nonsense-mediated mRNA decay. Blood.2002; 99: 1811-1816.","DOI":"10.1182\/blood.V99.5.1811"},{"key":"2020021223275779100_REF28","doi-asserted-by":"crossref","unstructured":"Carter AM, Sachchithananthan M, Stasinopoulos S, Maurer F, Medcalf RL. Prothrombin G20210A is a bifunctional gene polymorphism. Thromb Haemost.2002;87: 846-853.","DOI":"10.1055\/s-0037-1613095"},{"key":"2020021223275779100_REF29","doi-asserted-by":"crossref","unstructured":"Takagaki Y, Manley J. RNA recognition by the human polyadenylation factor CstF. Mol Cell Biol.1997;17: 3907-3914.","DOI":"10.1128\/MCB.17.7.3907"},{"key":"2020021223275779100_REF30","doi-asserted-by":"crossref","unstructured":"Zhao J, Hyman L, Moore C. Formation of mRNA 3\u2032 ends in eukaryotes: mechanism, regulation, and interrelationships with other steps in mRNA synthesis. Microbiol Mol Biol Rev.1999;63: 405-445.","DOI":"10.1128\/MMBR.63.2.405-445.1999"},{"key":"2020021223275779100_REF31","doi-asserted-by":"crossref","unstructured":"Moreira A, Takagaki Y, Brackenridge S, Wollerton M, Manley JL, Proudfoot NJ. The upstream sequence element of the C2 complement poly(A) signal activates mRNA 3\u2032 end formation by two distinct mechanisms. Genes Dev.1998;12: 2522-2534.","DOI":"10.1101\/gad.12.16.2522"},{"key":"2020021223275779100_REF32","doi-asserted-by":"crossref","unstructured":"Brackenridge S, Proudfoot NJ. Recruitment of a basal polyadenylation factor by the upstream sequence element of the human lamin B2 polyadenylation signal. Mol Cell Biol.2000;20: 2660-2669.","DOI":"10.1128\/MCB.20.8.2660-2669.2000"},{"key":"2020021223275779100_REF33","doi-asserted-by":"crossref","unstructured":"Natalizio BJ, Muniz LC, Arhin GK, Wilusz J, Lutz CS. Upstream elements present in the 3\u2032-untranslated region of collagen genes influence the processing efficiency of overlapping polyadenylation signals. J Biol Chem.2002;277: 42733-42740.","DOI":"10.1074\/jbc.M208070200"},{"key":"2020021223275779100_REF34","doi-asserted-by":"crossref","unstructured":"Chan L, Chang BH-J, Nakamuta M, Li W-H, Smith LC. Apobec-1 and apolipoprotein B mRNA editing. Biochim Biophys Acta.1997;1345: 11-26.","DOI":"10.1016\/S0005-2760(96)00156-7"},{"key":"2020021223275779100_REF35","doi-asserted-by":"crossref","unstructured":"Maniatis T, Tasic B. Alternative pre-mRNA splicing and proteome expansion in metazoans. Nature.2002;418: 236-243.","DOI":"10.1038\/418236a"},{"key":"2020021223275779100_REF36","doi-asserted-by":"crossref","unstructured":"Keegan LP, Gallo A, O'Connell MA. The many roles of an RNA editor. Nat Rev Genet.2001;2: 869-878.","DOI":"10.1038\/35098584"},{"key":"2020021223275779100_REF37","doi-asserted-by":"crossref","unstructured":"Edwalds-Gilbert G, Veraldi KL, Milcarek C. Alternative poly(A) site selection in complex transcription units: means to an end? Nucleic Acids Res.1997;25: 2547-2561.","DOI":"10.1093\/nar\/25.13.2547"},{"key":"2020021223275779100_REF38","doi-asserted-by":"crossref","unstructured":"Hentze MW, Kulozik AE. A perfect message: RNA surveillance and nonsense-mediated decay. Cell.1999;96: 307-310.","DOI":"10.1016\/S0092-8674(00)80542-5"},{"key":"2020021223275779100_REF39","doi-asserted-by":"crossref","unstructured":"Maquat LE, Carmichael GG. Quality control of mRNA function. Cell.2001;104: 173-176.","DOI":"10.1016\/S0092-8674(01)00202-1"},{"key":"2020021223275779100_REF40","doi-asserted-by":"crossref","unstructured":"Frischmeyer PA, Dietz HC. Nonsense-mediated mRNA decay in health and disease. Hum Mol Genet.1999;8: 1893-1900.","DOI":"10.1093\/hmg\/8.10.1893"},{"key":"2020021223275779100_REF41","doi-asserted-by":"crossref","unstructured":"Frischmeyer PA, van Hoof A, O'Donnell K, Guerrerio AL, Parker R, Dietz HC. An mRNA surveillance mechanism that eliminates transcripts lacking termination codons. Science.2002;295: 2258-2261.","DOI":"10.1126\/science.1067338"},{"key":"2020021223275779100_REF42","doi-asserted-by":"crossref","unstructured":"Wilkinson MF, Shyu AB. RNA surveillance by nuclear scanning? Nat Cell Biol.2002;4: E144-E147.","DOI":"10.1038\/ncb0602-e144"},{"key":"2020021223275779100_REF43","doi-asserted-by":"crossref","unstructured":"Faustino NA, Cooper TA. Pre-mRNA splicing and human disease. Genes Dev.2003;17: 419-437.","DOI":"10.1101\/gad.1048803"},{"key":"2020021223275779100_REF44","doi-asserted-by":"crossref","unstructured":"Brais B, Bouchard JP, Xie YG, et al. Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy. Nat Genet.1998;18: 164-167.","DOI":"10.1038\/ng0298-164"},{"key":"2020021223275779100_REF45","doi-asserted-by":"crossref","unstructured":"von Ahsen N, Oellerich M. The intronic prothrombin 19911A&gt;G polymorphism influences splicing efficiency and modulates effects of the 20210G&gt;A polymorphism on mRNA amount and expression in a stable reporter gene assay system. Blood.2004;103: 586-593.","DOI":"10.1182\/blood-2003-02-0419"},{"key":"2020021223275779100_REF46","doi-asserted-by":"crossref","unstructured":"Kaufmann I, Martin G, Friedlein A, Langen H, Keller W. Human Fip1 is a subunit of CPSF that binds to U-rich RNA elements and stimulates poly(A) polymerase. EMBO J.2004;23: 616-626.","DOI":"10.1038\/sj.emboj.7600070"},{"key":"2020021223275779100_REF47","doi-asserted-by":"crossref","unstructured":"Stein GS, Stein JL, van Wijnen AJ, Lian JB. Regulation of histone gene expression. Curr Opin Cell Biol.1992;4: 166-173.","DOI":"10.1016\/0955-0674(92)90028-B"},{"key":"2020021223275779100_REF48","doi-asserted-by":"crossref","unstructured":"Sparks KA, Dieckmann CL. Regulation of poly(A) site choice of several yeast mRNAs. Nucleic Acids Res.1998;26: 4676-4687.","DOI":"10.1093\/nar\/26.20.4676"},{"key":"2020021223275779100_REF49","doi-asserted-by":"crossref","unstructured":"Lou H, Gagel RF. Alternative RNA processing\u2014its role in regulating expression of calcitonin\/calcitonin gene-related peptide. J Endocrinol.1998; 156: 401-405.","DOI":"10.1677\/joe.0.1560401"},{"key":"2020021223275779100_REF50","doi-asserted-by":"crossref","unstructured":"Barabino SM, Keller W. Last but not least: regulated poly(A) tail formation. Cell.1999;99: 9-11.","DOI":"10.1016\/S0092-8674(00)80057-4"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/104\/2\/428\/1699967\/zh801404000428.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/104\/2\/428\/1699967\/zh801404000428.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T04:28:16Z","timestamp":1581568096000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/104\/2\/428\/18319\/The-prothrombin-3end-formation-signal-reveals-a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7,15]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,7,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2003-08-2894","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7,15]]}}}